NewEdge Advisors LLC Sells 10,106 Shares of Agilent Technologies, Inc. $A

NewEdge Advisors LLC reduced its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 36.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,951 shares of the medical research company’s stock after selling 10,106 shares during the quarter. NewEdge Advisors LLC’s holdings in Agilent Technologies were worth $2,046,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in A. Norges Bank acquired a new stake in shares of Agilent Technologies in the 4th quarter worth about $549,158,000. AQR Capital Management LLC boosted its stake in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Balyasny Asset Management L.P. raised its stake in shares of Agilent Technologies by 192.0% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock worth $192,204,000 after purchasing an additional 928,821 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of Agilent Technologies by 107.2% in the first quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company’s stock worth $190,900,000 after purchasing an additional 866,641 shares during the last quarter.

Analysts Set New Price Targets

A has been the topic of several analyst reports. Sanford C. Bernstein initiated coverage on Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Piper Sandler started coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target for the company. Barclays raised their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Finally, Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $148.55 on Friday. The company has a market capitalization of $41.95 billion, a P/E ratio of 29.83, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25. The company’s 50-day moving average is $135.38 and its 200 day moving average is $125.56. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.